Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0381120190410091055
Genes and Genomics
2019 Volume.41 No. 9 p.1055 ~ p.1062
Association of COX2 ?765G>C promoter polymorphism and coronary artery disease in Korean population
Kim In-Jai

Kim Sang-Hoon
Cha Dong-Hoon
Lim Sang-Wook
Moon Jae-Youn
Kim Jung-Oh
Ryu Chang-Soo
Park Han-Sung
Sung Jung-Hoon
Kim Nam-Keun
Abstract
Background: Cyclooxygenase-2 (COX2) plays a role in the formation of prostaglandins, which contribute to the inflammation involved in atherosclerosis. However, the role of the COX2 ?765G>C polymorphism in susceptibility to coronary artery disease (CAD) is controversial.

Objective: To identify the association between COX2 ?765G>C polymorphism with CAD risk in Korean patients. We recruited 622 patients who were diagnosed to have coronary artery disease and 202 controls who did not have history and vascular disease risk factors.

Methods: Using polymerase chain reaction-restriction fragment length polymorphism, the COX2 ?765G>C polymorphism was analyzed in 622 Korean patients who received percutaneous coronary intervention and in 202 healthy control subjects.

Results: The GC+CC genotype frequencies of the ?765G>C polymorphism were significantly different between the CAD and control groups. The COX2 ?765G>C polymorphism showed peculiar associations with CAD according to the presence of hyperlipidemia and plasma folate levels. However, there were no associations between the ?765G>C polymorphism and the rates of hypertension, diabetes mellitus, or homocysteine levels.

Conclusion: This study suggests that the COX2 ?765G>C polymorphism is a possible genetic determinant for the risk of CAD, and an individual risk factor in Koreans. Thus, further association studies between the COX2 polymorphism and atherosclerotic-related diseases such as cerebrovascular or cardiovascular diseases in other races or ethnicities will be needed.
KEYWORD
Polymorphism, Homocysteine, Coronary artery disease, Cyclooxygenase-2
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI)